Information Provided By: 
Fly News Breaks for August 6, 2019
FLGT
Aug 6, 2019 | 05:20 EDT
Piper Jaffray analyst William Quirk raised his price target for Fulgent Genetics to $9.50 from $5.30 following the company's better than expected Q2 results. The quarter was driven by a significant uptick in volumes, with 16,369 easily surpassing management's 10,000 test guidance, Quirk tells investors in a research note. Further, the analyst views management's raised 2019 revenue guidance to at least $29M as conservative. Nonetheless, the analyst keeps a Neutral rating on Fulgent Genetics.
News For FLGT From the Last 2 Days
There are no results for your query FLGT
